Loading...
Indian Pharmaceutical Exporter · #5 for Ofloxacin · $8.4M export value · DGFT Verified
Micro Labs Limited is the #5 Indian exporter of Ofloxacin with $8.4M in export value and 373 verified shipments. Micro Labs Limited holds a 2.8% market share in Ofloxacin exports across 33 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.
| $791.4K |
| 22 |
| 7.1% |
| MADAGASCAR | $728.3K | 92 | 6.5% |
| VIETNAM | $692.7K | 15 | 6.2% |
| JORDAN | $522.5K | 24 | 4.7% |
| NETHERLANDS | $386.9K | 31 | 3.5% |
| VIETNAM DEMOCRATIC REP. OF | $358.3K | 15 | 3.2% |
Micro Labs Limited exports Ofloxacin to 39 countries. The largest destination is FRANCE accounting for 24.5% of Micro Labs Limited's Ofloxacin shipments, followed by KENYA (10.7%) and UGANDA (8.6%). These destinations reflect Micro Labs Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| LABOREX UGANDA LIMITED | UGANDA | $1.7M | 84 |
| E.P.DIS | FRANCE | $1.4M | 73 |
| DANANG PHARMACEUTICAL- | VIETNAM, DEMOCRATIC REP. OF | $982.6K | 30 |
| E P DIS | FRANCE | $889.9K | 38 |
| AL-KAWKAB SCIENTIFIC BUREAU | JORDAN | $825.3K | 36 |
| MICRO NOVA PHARMACEUTICALS IND | NIGERIA | $810.0K | 37 |
| E.P.DIS.,., | FRANCE | $414.4K | 18 |
| DA NANG PHARMACEUTICAL MEDICAL | VIETNAM | $400.0K | 8 |
| SOMAPHAR | MADAGASCAR | $270.8K | 27 |
| M/S LABOREX KENYA LIMITED | KENYA | $234.9K | 15 |
Micro Labs Limited supplies Ofloxacin to 93 buyers globally. The largest buyer is LABOREX UGANDA LIMITED (UGANDA), followed by E.P.DIS (FRANCE) and DANANG PHARMACEUTICAL- (VIETNAM, DEMOCRATIC REP. OF). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $71.8M worth of Ofloxacin through 15,000 shipments from 1094 suppliers to 180 countries, serving 3,093 buyers globally. Micro Labs Limited contributes $8.4M to this total, accounting for 2.8% of India's Ofloxacin exports. Micro Labs Limited ships Ofloxacin to 39 countries through 93 buyers.
Micro Labs Limited's average Ofloxacin shipment value is $22.5K per consignment, based on 373 shipments totaling $8.4M. The largest destination is FRANCE (24.5% of Micro Labs Limited's Ofloxacin exports).
Micro Labs Limited ranks #5 among 1094 Indian Ofloxacin exporters with a 2.8% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($12.2M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($10.1M), MICRO LABS LIMITED ($8.4M). Micro Labs Limited processed 373 shipments to 33 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| MICROLUSS (CIPROFLOXACIN TABLETS USP 500 | $250.0K | 5 |
| ORNILOX (ORNIDAZOLE 500MG & OFLOXACIN 20 | $246.9K | 12 |
| ORNILOX ( (Ornidazole 500mg & Ofloxacin | $207.0K | 10 |
| ORNILOX ( (Ofloxacin + Ornidazole Tablet | $187.5K | 5 |
| LEVOFLOXACIN DISPERSIBLE TABLETS 100 MG10x10'sx3499=349900 NOS | $129.6K | 3 |
| ORNILOX (ORNIDAZOLE 500MG + OFLOXACIN 20 | $124.8K | 5 |
| MICROLUSS (CIPROFLOXACIN TABLETS USP 500MG) (10X10SX51896) - TAX INVOICE NO: 701208452 DT: 17.02.2024NOS | $114.1K | 3 |
| MICROLUSS (CIPROFLOXACIN TABLETS USP 500MG) (10X10sX48802) - TAX INVOICE NO: 701208498 DT: 29.02.2024NOS | $106.7K | 3 |
| MICROFLOX 500 (CIPROFLOXACIN 500MG USP T | $100.0K | 2 |
| MICROLUSS CIPROFLOXACIN TABLETS USP 500MG 10X10sX59544 - TAX DOCUMENT NO: 712202715 DT: 16.11.2023 | $100.0K | 2 |
Micro Labs Limited exports 499 distinct Ofloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MICROLUSS (CIPROFLOXACIN TABLETS USP 500 with 5 shipments worth $250.0K.
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | MACLEODS PHARMACEUTICALS LTD | $12.2M | 243 | 33 | $50.0K |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $10.1M | 202 | 20 | $50.0K |
| 5 | MICRO LABS LIMITED ★ | $8.4M | 373 | 33 | $22.5K |
| 6 | AUROBINDO PHARMA LTD | $7.2M | 172 | 12 | $42.0K |
| 7 | SENTISS PHARMA PRIVATE LIMITED | $6.3M | 130 | 7 | $48.7K |
Micro Labs Limited ranks #5 among 1094 Indian Ofloxacin exporters. Average shipment value of $22.5K compared to the market average of $65.6K. The closest competitors by value are MACLEODS PHARMACEUTICALS LTD and SUN PHARMACEUTICAL INDUSTRIES LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,841 | 12.3% |
| DELHI AIR CARGO ACC (INDEL4) | 1,504 | 10.0% |
| SAHAR AIR | 1,292 | 8.6% |
| NHAVA SHEVA SEA (INNSA1) | 1,262 | 8.4% |
| DELHI AIR | 894 | 6.0% |
| Bombay Air | 655 | 4.4% |
| JNPT/ NHAVA SHEVA SEA | 645 | 4.3% |
| Delhi Air | 361 | 2.4% |
Micro Labs Limited also exports these advanced antibiotics products. Each links to the detailed product page.
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.
The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)
Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)
However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.
Micro Labs Limited exports 76 products worth $463.6M. Beyond Ofloxacin, top products include Amoxicillin, Potassium, Gabapentin, Losartan, Esomeprazole. View the complete Micro Labs Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Ofloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 180+ countries, 3,093+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Micro Labs Limited's Ofloxacin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Micro Labs Limited
Full Company Profile →
76 products · $463.6M total trade · 21 categories
Access shipment-level records, pricing trends, and buyer contacts for Micro Labs Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ofloxacin. For current shipment-level data, contact TransData Nexus.